glutathione protein modification System from Cyanobacteria to Higher Eukaryotes Glutaredoxin catalysis requires two distinct

10.1002/hipo.1061 3 ArancibiaS.RageF.GraugesP.GomezF.Tapia-ArancibiaL.ArmarioA

[DOI] [PMC free article] [PubMed] [Google Scholar] 46.Taniguchi K, Karin M

FNDC5/irisin ameliorates bone loss of type 1 diabetes by suppressing endoplasmic reticulum stress-mediated ferroptosis

Methotrexate remains a cornerstone in psoriasis management, achieving PASI 75 in about 4050% of patients after 16 weeks of therapy

Emphasizing the overlap and differences between bench and bedside research findings, we examine the translational potential of proposed metabolic biomarkers for improving TBI management and as therapeutic targets

The Two Structural Modifications and Their Research Significance Analogues with substitutions, deletions, or insertions at the N-terminal end of native IGF-1 were found to reduce binding to IGFBPs and increase bioavailability to IGF-1R on cells a principle exploited in the design of LR3, where the arginine substitution and N-terminal extension together confer superior IGFBP evasion compared to shorter analogues such as Arg3 IGF-1, Gly3 IGF-1, and Des(1-3) IGF-1